Product Information

METFORMIN ER 1,000 MG GASTR-TB is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.3336 per EA under NDC 50228044690. Its NADAC has been published 260 times since Sep 1, 2021.

FDA first approved this application on Apr 16, 2021. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METFORMIN ER 1,000 MG GASTR-TB

Metformin Hydrochloride Extended-Release Tablets
$0.3336per EA

Strength

1000 mg/1

NDC

50228044690

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213334

FDA Approved

4/16/2021

TE Code

AB3

On Market Since

4/16/2021

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN ER 1,000 MG GASTR-TB has been published 260 times since Sep 1, 2021, and over the history we have for it it has declined 94.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3336 per EA
All-time high$7.1715 (Oct 13, 2021)
All-time low$0.3336 (Aug 19, 2026)
52-week high$0.5124
52-week low$0.3336
Median price$1.2953
Average price$1.8690
Largest weekly change+118.1% (Feb 23, 2022)
Weeks tracked260
Tracking sinceSep 1, 2021

Price History

1W

-4.4%

1M

-4.4%

3M

-18.9%

6M

-16.4%

1Y

-31.5%

3Y

-85.1%

5Y

N/A

All

-94.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 2%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of METFORMIN ER 1,000 MG GASTR-TB?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN ER 1,000 MG GASTR-TB, manufactured by ScieGen Pharmaceuticals, Inc., is $0.3336 per EA (NDC 50228044690), effective Aug 19, 2026.

How has the price of METFORMIN ER 1,000 MG GASTR-TB changed over time?

Over the history we have for it, the NADAC for METFORMIN ER 1,000 MG GASTR-TB has declined 94.4%. It has been tracked across 260 weekly CMS publications since Sep 1, 2021.

What are the highest and lowest recorded NADAC prices for METFORMIN ER 1,000 MG GASTR-TB?

Since Sep 1, 2021, the NADAC for METFORMIN ER 1,000 MG GASTR-TB has ranged from a low of $0.3336 (Aug 19, 2026) to a high of $7.1715 (Oct 13, 2021), with a median of $1.2953 per EA.

Are there cheaper alternatives to METFORMIN ER 1,000 MG GASTR-TB?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN ER 1,000 MG OSM-TAB, is $0.3262 per EA — about 2% below METFORMIN ER 1,000 MG GASTR-TB.

Who manufactures METFORMIN ER 1,000 MG GASTR-TB?

METFORMIN ER 1,000 MG GASTR-TB (NDC 50228044690) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.